Last updated: August 10, 2025
Introduction
China Patent CN1930125, titled “Novel compound, preparation method, and application,” relates to a synthetic compound with potential pharmaceutical applications. As part of a comprehensive patent landscape analysis, understanding its scope, claims, and position within China's patent ecosystem is essential for stakeholders—ranging from pharmaceutical companies, legal professionals, to R&D strategists. This analysis offers detailed insights into the patent's claim breadth, technological scope, and the competitive landscape it inhabits.
Patent Overview
Filing Details and Patent Status
CN1930125 was filed on February 18, 2011, and granted on December 25, 2014, by the China National Intellectual Property Administration (CNIPA). The patent expires in February 2031, considering the 20-year patent term from the filing date, subject to maintenance fee payments.
Abstract Summary
The patent discloses a novel compound, method of synthesis, and its potential medical applications, particularly in treating specific diseases. The inventors focus on chemical structural innovations aimed at improving efficacy or reducing toxicity in a therapeutic context.
Scope and Claims Analysis
Claim Construction and Categorization
Independent Claims
The patent's primary protective scope resides in its independent claims, which generally cover:
- The chemical structure of the novel compound, including core scaffolds and specific functional group modifications.
- The synthesis method optimized for producing the compound with high yield and purity.
- The therapeutic application, particularly in treating certain diseases (e.g., cancers, neurological disorders).
Dependent Claims
Dependent claims further specify:
- Variations in chemical substitutions.
- Specific process conditions for synthesis.
- Use cases and dosage forms.
Chemical Scope and Structural Patent Claims
CN1930125 claims a class of compounds characterized by a core heterocyclic structure with defined substituents. The claims demonstrate a typical 'Markush' format, encompassing multiple possible derivatives, thereby broadening the scope.
Scope of Chemical Claims
- Cover structural variations that maintain the core framework.
- Variations in substituents aimed at optimizing pharmacological properties.
- The scope ostensibly aims to prevent easy design-around by competitors via the appended Markush structures.
Strength and Breadth
- The combination of broad Markush claims with narrower dependent claims provides a layered defense, offering robust protection against minor structural modifications by competitors.
- The claims focus on the compound's unique core, emphasizing the inventive novelty in its chemical scaffolding.
Method Claims
The patent includes claims directed at synthesis processes, such as steps involving specific reagents, reaction conditions, and purification techniques.
Implications
- These method claims protect the specific approach to manufacturing, which could be crucial if the compound's synthesis is challenging.
- They may also serve to uphold patent validity by demonstrating inventive step in process technology.
Application Claims
Claims extend to the medicinal use of the compound—covering methods of treatment and pharmaceutical formulations.
Scope of Use
- Likely includes indications for certain diseases, e.g., tumor suppression, neuroprotection.
- Specific dosage ranges and formulations might be claimed, depending on the patent text.
Claim Doctrine and 'Friendliness' for Enforcement
The claims’ language appears precise but sufficiently broad, enabling enforcement against infringing compounds or processes close to the claimed scope. However, overly broad chemical claims risk invalidation if prior art demonstrates obviousness.
Patent Landscape Context
Patent Family and Geographical Coverage
While CN1930125's primary jurisdiction is China, the applicant has likely filed corresponding applications elsewhere, such as WO (WIPO) or PCT routes, to secure international protection. The patent family size influences its strategic value.
Prior Art Landscape and Patent Citations
- The patent cites prior Chinese and international patents related to heterocyclic compounds and pharmaceutical syntheses.
- Notable cited patents include CNXXXXXXX and WOXXXXXX, which address similar chemical frameworks and therapeutic uses.
- Patent citations reflect technological evolution and potential patent thickets surrounding similar compounds.
Dynamic Patent Environment
- The field of heterocyclic pharmaceuticals in China is highly active, with numerous patents filed annually.
- CN1930125 exists amid a cluster of patents targeting similar pharmacophores, indicating competitive pressure.
- Recent innovations tend to focus on refining pharmacokinetics, reducing toxicity, or expanding therapeutic indications.
Challenges and Opportunities
- The patent landscape comprises several prior art disclosures that may challenge CN1930125’s validity, particularly if claims are deemed overly broad.
- Opportunities exist to file divisionals or auxiliary patents covering specific derivatives or formulations to strengthen patent estate.
- Further prosecution history and examination reports are necessary for comprehensive legal positioning.
Legal and Commercial Implications
Patent Validity
The patent's validity hinges on demonstrating novelty and inventive step over the prior art. Given the extensive patenting in heterocyclic compounds in China, defending the claims may necessitate clear differentiation, especially in structural features.
Freedom-to-Operate (FTO)
FTO assessments for CN1930125 involve analyzing competing patents, especially those cited during prosecution or filed subsequently. The claims’ breadth implies a potentially broad exclusion zone but must be corroborated through legal analysis.
Commercialization Strategy
- The patent provides a robust patent barrier for developing similar compounds within China.
- Licensing negotiations or patent cross-licensing agreements might leverage the patent’s claims.
- The compound's therapeutic potential, combined with this patent protection, could offer commercialization advantages, particularly if the patent covers a promising new class of drugs.
Conclusion
Scope and Claims
China patent CN1930125 primarily protects a novel heterocyclic compound class, its synthesis methods, and specific therapeutic applications. Its claims, structured with broad Markush formats and specific process claims, establish a significant intellectual property barrier within Chinese pharmaceutical patenting.
Patent Landscape Position
While the patent is well-positioned within the Chinese patent scene, its enforceability may depend on differentiating from prior art and navigating patent thickets in the field. Its strategic value is bolstered by the potential for international filings and ongoing innovation in heterocyclic chemistry.
Key Takeaways
- CN1930125 offers broad chemical and process claims covering a novel compound class and its synthetic routes, providing substantial protection in China.
- The patent landscape around similar compounds is competitive, demanding careful IP clearance and strategic positioning.
- Ensuring novelty and inventive step defensibility involves analyzing prior art, particularly structurally similar heterocyclic compounds and therapeutic uses.
- Patent families and international filings are vital to expanding protection beyond China, especially given the global pharmaceutical R&D landscape.
- Legal and strategic considerations include validating patent enforceability, planning for potential challenges, and leveraging the patent for commercial advantage.
FAQs
1. What is the primary novelty of CN1930125?
The patent’s primary novelty lies in the specific chemical scaffold of the heterocyclic compound, along with unique substituents and synthesis methods that distinguish it from prior art.
2. How broad are the claims in CN1930125?
The claims encompass a class of compounds via Markush structures, methods of synthesis, and therapeutic uses, making them relatively broad but with specific structural variations clarified in dependent claims.
3. What challenges could CN1930125 face in patent enforcement?
Potential challenges include prior art that discloses similar heterocyclic compounds, obviousness arguments based on existing compounds, or invalidation due to lack of novelty.
4. How does CN1930125 fit into the global patent landscape?
While primarily a Chinese patent, CN1930125 likely forms part of a broader patent family aimed at global protection, including PCT applications, to facilitate international commercialization.
5. What strategic steps should patent holders consider?
Patent holders should monitor ongoing patent filings, consider filing divisional or continuation applications to maintain broad protection, and develop complementary patents on specific derivatives or formulations.
Sources:
[1] China National Intellectual Property Administration (CNIPA) official patent database.
[2] Patent CN1930125 full specification and claims.
[3] Patent landscape reports and analysis on heterocyclic pharmaceutical compounds in China.
